GROUP ONE TRADING LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 215 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$4,336,452
+535.9%
399,305
+997.3%
0.02%
+466.7%
Q1 2024$681,930
+1488.5%
36,389
+1736.9%
0.00%
Q4 2023$42,928
-94.5%
1,981
-94.8%
0.00%
-100.0%
Q3 2023$780,785
+33.8%
37,939
+205.7%
0.00%
+50.0%
Q2 2023$583,612
-3.7%
12,412
-14.1%
0.00%0.0%
Q1 2023$605,944
-21.1%
14,441
-28.3%
0.00%0.0%
Q4 2022$768,101
-8.7%
20,139
-6.2%
0.00%0.0%
Q3 2022$841,000
+74.1%
21,472
+43.5%
0.00%
+100.0%
Q2 2022$483,000
+2918.8%
14,958
+3055.7%
0.00%
Q1 2022$16,000
-84.0%
474
-79.8%
0.00%
Q4 2021$100,000
-75.8%
2,349
-74.9%
0.00%
Q3 2021$414,000
-91.9%
9,349
-89.6%
0.00%
-100.0%
Q2 2021$5,129,000
+1029.7%
90,275
+1388.9%
0.01%
+500.0%
Q1 2021$454,000
-31.8%
6,063
-44.4%
0.00%
-50.0%
Q3 2020$666,000
-40.9%
10,898
-59.8%
0.00%
-60.0%
Q2 2020$1,126,000
+15.1%
27,083
-20.5%
0.01%
-37.5%
Q1 2020$978,000
+92.1%
34,066
+839.2%
0.01%
+100.0%
Q3 2019$509,000
-34.9%
3,627
-55.6%
0.00%
-42.9%
Q4 2018$782,000
+586.0%
8,166
+347.9%
0.01%
+600.0%
Q3 2017$114,000
-80.7%
1,823
-75.4%
0.00%
-83.3%
Q2 2017$590,000
-11.9%
7,412
-21.4%
0.01%
-25.0%
Q1 2017$670,000
+885.3%
9,430
+603.7%
0.01%
+700.0%
Q4 2016$68,000
-60.5%
1,340
-76.5%
0.00%
-50.0%
Q2 2016$172,000
+805.3%
5,700
+850.0%
0.00%
Q1 2016$19,000
-91.0%
600
-88.0%
0.00%
-100.0%
Q3 2015$212,000
+28.5%
5,000
+121.7%
0.00%
+50.0%
Q2 2015$165,0002,2550.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 255,000$18,123,00010.69%
Clarius Group, LLC 149,068$10,594,0004.38%
GREAT POINT PARTNERS LLC 301,809$21,450,0004.26%
GREAT POINT PARTNERS LLC 300,000$21,321,0004.23%
Sio Capital Management, LLC 102,800$7,306,0004.09%
Palo Alto Investors LP 1,101,951$78,316,0003.70%
New Leaf Venture Partners, L.L.C. 99,123$7,045,0003.61%
DLD Asset Management, LP 245,800$17,466,0002.80%
First Light Asset Management, LLC 93,465$6,643,0002.54%
DLD Asset Management, LP 220,300$15,655,0002.51%
View complete list of SAGE THERAPEUTICS INC shareholders